PROMOTE: A prospective randomised trial comparing embryo development

ISRCTN ISRCTN73037149
DOI https://doi.org/10.1186/ISRCTN73037149
Secondary identifying numbers 17907
Submission date
08/01/2015
Registration date
12/01/2015
Last edited
27/10/2022
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Pregnancy and Childbirth
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Background and study aims
The EmbryoScope™ is an IVF incubator with built in camera that monitors the development of embryos around the clock. It provides a safe incubator environment from conception thogh to time of transfer.
This trial examines whether an Embryoscope provides a better environment to culture embryos in when compared to a traditional MINC benchtop incubator. The Embryoscope allows the developing embryo to be imaged at regular intervals without removing them from the incubator thus providing them with a constant environment.

Who can participate?
Couples who have more than 6 healthy embryos

What does the study involve?
The embryos are randomly allocated into one of two groups. Those in group 1 are placed in the EmbryoScope™. Those in group 2 are placed in the MINC incubator. The embryos are assessed by examining their structure and form (morphology) and how this changes over time (morphokinetics). In addition to this, the metabolism of the embryos are examined by measuring the concentrations of essential nutrients in the culture medium. This is because it is thought that "quiet" embryos i.e. those who use less nutrients, are in fact more viable.

What are the possible benefits and risks of participating?
Not provided at time of registration

Where is the study run from?
University of Southampton (UK)

When is the study starting and how long is it expected to run for?
January 2015 to December 2015

Who is funding the study?
1. Unisense FertiliTech A/S (Denmark)
2. National Institute for Health Research (UK)

Who is the main contact?
Dr Alexandra Kermack

Contact information

Dr Alexandra Kermack
Scientific

University of Southampton
Academic Unit of Genetic Medicine
Coxford Road
Southampton
SO16 5YA
United Kingdom

Study information

Study designRandomised; Interventional
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titlePROMOTE: A Prospective Randomised trial cOmparing embryo Metabolism and develOpmenT in the standard versus the Embryoscope incubator
Study acronymPROMOTE
Study hypothesisAre embryos cultures in an Embryoscope more likely to reach blastocyst stage when compared with those cultured in a MINC benchtop incubator? The research question is being posed because the Embryoscope is an incubator which allows embryos to be observed without removing them from the culture chamber, and there is some evidence to suggest that these embryos benefit from more stable conditions.
Ethics approval(s)NRES Committee South Central – Berkshire, 03/11/2014, ref: 14/SC/1260
ConditionTopic: Reproductive health and childbirth; Subtopic: Reproductive Health and Childb (all Subtopics); Disease: Reproductive Health & Childbirth
Intervention1. Embryoscope: Half of the female participant's embryos will be cultured in the Embryoscope
2. MINC benchtop incubator: Half of the female participant's embryos will be cultured in the MINC benchtop incubator
Intervention typeProcedure/Surgery
Primary outcome measureProportion of embryos reaching blastocyst stage in Embryoscope versus MINC benchtop incubator on day 5 after culture in the Embryoscope
Secondary outcome measures1. A comparison of the mean morphology score of embryos from each cohort on day 5 after culture in the Embryoscope versus the MINC incubator
2. Number of embryos suitable for cryopreservation from Embryoscope versus MINC
3. Number of “usable” embryos from Embryoscope versus MINC
4. Implantation rate in relation to metabolic activity of embryo(s) transferred
5. A comparison of the amino acid profile in the conditioned media obtained from blastocysts after culture in the Embryoscope versus the MINC Incubator
6. Correlation between metabolic activity and embryo viability as assessed by morphological and morphokinetic assessment
Overall study start date05/01/2015
Overall study end date31/12/2015

Eligibility

Participant type(s)Patient
Age groupAdult
SexFemale
Target number of participantsPlanned Sample Size: 120; UK Sample Size: 120; Description: 60 couples but consented individually
Participant inclusion criteria1. Standard indication for IVF/ICSI treatment
2. Good understanding of written and spoken English
3. Female age under 42
4. Antral Follicle Count (AFC) of more than 15 or Anti Mullerian Hormone (AMH) of more than 10pmol/l
Participant exclusion criteria1. Any medical contraindication to IVF/ICSI
2. Previous diagnosis of HIV, Hep B or Hep C
3. High risk of Ovarian Hyperstimulation Syndrome (OHSS) as assessed prior to triggering of final oocyte maturation
4. Less than 6 2PN zygotes or more than 14 2PN zygotes available for culture
Recruitment start date15/01/2015
Recruitment end date30/10/2015

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

University of Southampton
Academic Unit of Genetic Medicine
Coxford Road
Southampton
SO16 5YA
United Kingdom

Sponsor information

Southampton University Hospitals NHS Trust
Hospital/treatment centre

Cancer Care Directorate
B Level, Mailpoint WRE
Royal South Hants Hospital
Graham Road
Southampton
SO14 0YG
England
United Kingdom

ROR logo "ROR" https://ror.org/0485axj58

Funders

Funder type

Government

Unisense FertiliTech A/S (Denmark)

No information available

National Institute for Health Research
Government organisation / National government
Alternative name(s)
National Institute for Health Research, NIHR Research, NIHRresearch, NIHR - National Institute for Health Research, NIHR (The National Institute for Health and Care Research), NIHR
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing planNot provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article 26/10/2022 27/10/2022 Yes No
HRA research summary 28/06/2023 No No

Editorial Notes

27/10/2022: Publication reference added.
19/01/2018: No publications found, verifying study status with principal investigator.